BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CM383 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of CM383\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06619613-673@assetmemo.bio
DTSTAMP:20261121T004552Z
DTSTART;VALUE=DATE:20261230
DTEND;VALUE=DATE:20261231
SUMMARY:CM383: Phase 1 readout est. (NCT06619613)
DESCRIPTION:CM383\, phase 1\, Alzheimer's Disease.\nStudy: A Study of CM383
  in Patients With Alzheimer's Disease Related Mild Cognitive Impairment an
 d Mild Alzheimer's Disease\nEstimated primary completion: 30 December 2026
 . This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, a
 nd it can move.\nDrug page: https://assetmemo.bio/drug/cm383#upcoming-even
 ts\nRegistry record: https://clinicaltrials.gov/study/NCT06619613
URL:https://assetmemo.bio/drug/cm383#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
